Upcoming Industry Partner Series Presentation: Tirzepatide in Type II Diabetes

Posted over 1 year ago by Ledyenska Ballesteros

Tirzepatide in Type II Diabetes

Webinar/Online

Thursday, September 8, 2022 at 7:30pm CT - 8:30pm CT

PAOM would like to welcome its members to join us in our upcoming Partner Series Presentation on Tirzepatide in Type II Diabetes. Speakers, Amy Ingersoll, PA-C, MMS, FOMA and Jay Porter, PhD , Obesity Medical Science Liaison, will discuss the recently released medication, Tirzepatide (also known as Mounjaro), in hopes of helping medical practitioners better understand the medication and its affects on DMII and obesity.

The objectives of this lecture include:

Review potential mechanism of action of GIP and GLP
Review safety and efficacy of Tirzepatide in Type 2 Diabetes
Review Tirzepatide US Product Information*

Info

Topic

Obesity Medicine

Speaker(s)

Amy Ingersoll, PA-C, MMS, FOMA and Jay Porter, PhD , Obesity Medical Science Liaison

Additional Information

** This event is available to official members of PAs in Obesity Medicine ONLY.

This presentation is designed to help medical practitioners better understand the recently released medication, Tirzepatide (also known as Mounjaro.)

The objectives of this lecture include:

Review potential mechanism of action of GIP and GLP
Review safety and efficacy of Tirzepatide in Type 2 Diabetes
Review Tirzepatide US Product Information*